Download Files:
p38 MAP Kinase Inhibitor IV
SKU
HY-112401-5mg
Category Reference compound
Tags Inflammation/Immunology, MAPK/ERK Pathway, p38 MAPK
$144
Only 1000 item(s) left in stock.
Products Details
Product Description
– p38 MAP Kinase Inhibitor IV is a highly specific ATP-competitive p38α MAPK inhibitor with IC50s of 0.13 and 0.55 μM for p38α and p38β MAPK, respectively[1].
Web ID
– HY-112401
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C12H4Cl6O4S
References
– [1]Liu YC, et al. Identification of a novel competitive inhibitor of p38alpha MAPK by a human PBMC screen. Biochem Biophys Res Commun. 2007;352(3):656-661.
CAS Number
– 1638-41-1
Molecular Weight
– 456.94
SMILES
– OC1=C(Cl)C=C(Cl)C(Cl)=C1S(=O)(C2=C(O)C(Cl)=CC(Cl)=C2Cl)=O
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– p38 MAPK
Isoform
– p38α;p38β;p38δ
Pathway
– MAPK/ERK Pathway
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.